Moderna Stock Is Over 4% Up So Far Today

Shares of Moderna jumped 4.86% to $93.21 at 11:05 EST on Thursday. The Nasdaq Stock Market is jumping 0.14% to $11818.4, on what seems, as yet, an all-around positive exchanging session on The Nasdaq Stock Market. This was the IXIC 2 consecutive sessions of losses. According to today's article on Bloomberg Quint, "Moderna Vaccine Production Is Gearing Up, Partner Lonza Says." Moderna's last close was $88.89, below its 52-week high of $103.2. Moderna's sales growth is 1216.8% for the present quarter and 2299% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 67.6% and a positive 142.9%, respectively. Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months. Moderna's stock is valued at $93.21 at 11:05 EST, under its 52-week high of $103.2 and way higher than its 52-week low of $17.68. Moderna's worth is way above its 50 day moving average of $74.76 and way higher than its 200 day moving average of $68.76.

Moderna on the News

Moderna vaccine found highly effective at preventing covid. According to Bloomberg Quint on Mon Nov 16, "Moderna shares rose more than 9% in pre-market U.S." According to MarketWatch on Mon Nov 16, "Stock futures surge as Moderna says coronavirus vaccine is 94.5% effective in trial." Moderna shares soar premarket after coronavirus vaccine candidate achieves 94.5% efficacy in phase 3 trial, according to MarketWatch on Mon Nov 16. Update: Moderna shares soar premarket after coronavirus vaccine candidate achieves 94.5% efficacy in phase 3 trial. According to MarketWatch on Mon Nov 16. According to MarketWatch on Mon Nov 16, "Moderna shares have surged 18% in premarket on coronavirus vaccine trial data." According to Bloomberg Quint on Mon Nov 16, "NYC-Linked Stocks Climb on Optimism Over Moderna Vaccine Results." According to Bloomberg Quint on Mon Nov 16, "European Stocks Surge to February High on Moderna Vaccine Study." According to Bloomberg Quint on Tue Nov 17, "Moderna Vaccine Offers Possible Antidote to Deep-Freeze Problem."